The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
How Does The Forecasted Market Size Of The Breast Cancer Diagnostics Market Compare Between 2026 And 2030?
The breast cancer diagnostics market size has shown robust growth in recent years. It is projected to increase from $5 billion in 2025 to $5.42 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.3%. The expansion observed in past periods is attributable to factors such as the rising global prevalence of breast cancer, greater public understanding of early cancer screening, the broadening of diagnostic imaging infrastructure, the increasing availability of biomarker-based tests, and advancements in the accuracy and safety of biopsies.
The breast cancer diagnostics market size is projected to experience robust expansion over the upcoming years. This market is set to reach $7.28 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.7%. Factors contributing to this growth during the forecast period include the expanding use of precision oncology diagnostics, increased investments in AI-powered diagnostic platforms, a heightened demand for less invasive testing methods, the proliferation of population-based screening initiatives, and ongoing innovations in molecular diagnostic technologies. Key trends anticipated for the forecast timeframe involve a greater uptake of AI-assisted imaging analysis, a surge in genomic and molecular testing applications, the broader implementation of liquid biopsy techniques, the spread of advanced non-ionizing imaging modalities, and an intensified emphasis on early and customized diagnosis.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3284&type=smp
What Primary Factors Are Fueling The Expansion Of The Breast Cancer Diagnostics Market?
Government initiatives and dedicated funding for breast cancer are anticipated to fuel the expansion of the breast cancer diagnostics market moving forward. Such government support encompasses financial aid provided to selected entities whose proposals or projects contribute to and improve public services and the economy. These governmental efforts play a vital role in bolstering breast cancer research, prevention, and treatment, with various programs established to heighten awareness, encourage early detection through screening and mammography services, and provide financial assistance for breast cancer testing and care to underserved communities. As an illustration, The Australian Government Department of Health (DoH), the Australia-based Government agency, earmarked $40.7 million in its 2022-23 budget. This allocation aimed to boost the availability of testing and screening services for diverse cancers, offsetting delays caused by the COVID-19 pandemic, and ensuring timely referrals, rapid diagnosis, and early intervention, with $9.7 million specifically allocated for breast cancer screening. Hence, government initiatives and funding for breast cancer are propelling the growth of the breast cancer diagnostics market.
How Is The Breast Cancer Diagnostics Market Distributed Across Key Segments?
The breast cancer diagnostics market covered in this report is segmented –
1) By Type: Imaging, Biopsy, Genomic Tests, Blood Tests, Other Types
2) By Technology: Fluorescent In Situ Hybridization (FISH), Comparative Genomic Hybridization (CGH), Immunohistochemical (IHC), Other Technologies
3) By Cancer Type: BRCA Breast Cancer, ER And PR Breast Cancer, HER 2 Breast Cancer, Triple-Negative Breast Cancer, Other Cancer Types
4) By Diagnostic Type: Ionizing Breast Imaging Technologies, Non-ionizing Imaging Technologies
5) By End Users: Hospitals And Clinics, Cancer Research Centers, Diagnostic Laboratories, Ambulatory Surgical Centers
Subsegments:
1) By Imaging: Mammography, Ultrasound Imaging, Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), Tomosynthesis
2) By Biopsy: Needle Biopsy, Core Needle Biopsy, Fine Needle Aspiration Biopsy (FNA), Stereotactic Biopsy
3) By Genomic Tests: Oncotype DX, MammaPrint, PAM50, BRCA1 Or 2 Testing
4) By Blood Tests: Liquid Biopsy, Circulating Tumor DNA (ctDNA) Tests, Circulating Tumor Cells (CTCs) Tests
5) By Other Types: Hormone Receptor Tests, HER2 Tests, Genetic Mutation Testing
Which Trends Are Guiding The Development Of The Breast Cancer Diagnostics Market?
Leading companies within the breast cancer diagnostics market are prioritizing the creation of innovative AI-powered diagnostic solutions, including advanced pathology scoring platforms, to boost precision, optimize workflows, and enable individualized treatment planning. These AI-driven diagnostic platforms incorporate machine learning and deep-learning algorithms to analyze medical imaging, pathology slides, or clinical data, subsequently providing diagnostic insights or risk stratifications that aid clinical decision-making. For instance, in September 2024, Ibex Medical Analytics, an Israel-based digital pathology company, unveiled its expanded AI platform dedicated to breast cancer diagnostics, which notably introduced a fully automated zero-click HER2 immunohistochemistry (IHC) scoring feature within its Ibex Breast HER2 module. This tool effectively identifies invasive cancer regions, categorizes HER2 expression levels (0, 1+, 2+, 3+), and supports breast cancer diagnosis and treatment-pathway determinations with enhanced accuracy and workflow efficiency.
Who Are The Leading Firms Participating In The Breast Cancer Diagnostics Market?
Major companies operating in the breast cancer diagnostics market are Abbott Laboratories, Myriad Genetics Inc., Hologic Inc., Koninklijke Philips N.V., Fujifilm Holdings Corporation, GE Healthcare, Thermo Fisher Scientific Inc., Siemens AG, NanoString Technologies Inc., Gamma Medica Inc., Aurora Imaging Technology Inc., Dilon Technologies Inc., Exact Sciences Corporation, F. Hoffmann-La Roche Ltd., Micrima Limited, Provista Diagnostics Inc., Leica Biosystems Nussloch GmbH, bioTheranostics Inc., Bio-Rad Laboratories Inc., Illumina Inc., Biocept Inc., Quest Diagnostics Incorporated, Agilent Technologies Inc., Cepheid, Guardant Health Inc., Invitae Corporation, Natera Inc., NeoGenomics Laboratories Inc., Oncocyte Corporation, PerkinElmer Inc., Sysmex Corporation, Veracyte Inc.
Access The Complete Breast Cancer Diagnostics Market Report:
https://www.thebusinessresearchcompany.com/report/breast-cancer-diagnostics-global-market-report
Which Region Is The Dominant Market In The Breast Cancer Diagnostics Market?
North America was the largest region in the breast cancer diagnostics market in 2025. Asia-Pacific was the second largest region in the breast cancer diagnostics industry. The regions covered in the breast cancer diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access a Customized Breast Cancer Diagnostics Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=3284&type=smp
Browse Through More Reports Similar to the Global Breast Cancer Diagnostics Market 2026, By The Business Research Company
Next Generation Gynecological Cancer Diagnostics Market Report 2026
Cancer Diagnostics Market Report 2026
https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report
Breast Imaging Technologies Market Report 2026
https://www.thebusinessresearchcompany.com/report/breast-imaging-technologies-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model